Clinical Trials Directory

Trials / Completed

CompletedNCT07108933

Scheduled Autologous PRP Guided Injection in the Maxillary Bony Defects

Effect of Scheduled Autologous Platelet-rich Plasma Guided Injection in the Healing Process of Critical-sized Maxillary Bony Defects After Surgical Excision of Non- Malignant Lesions: A Prospective Randomized Clinical Trial.

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Horus University · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Scheduled autologous platelet-rich plasma guided injection is done in critical-sized maxillary bony defects after surgical excision of non- malignant lesions.

Detailed description

The study aims to detect the effect of scheduled autologous platelet-rich plasma- guided injection in the healing process of critical-sized maxillary bony defects after surgical removal of non-malignant lesions by using bone volumetric analysis and density measuring with cone beam computed tomography.

Conditions

Interventions

TypeNameDescription
BIOLOGICALAutologous platelet-rich plasmaGuided injection of PRP in bony cavities of maxilla after surgical excision of non-malignant tumors.

Timeline

Start date
2023-08-15
Primary completion
2024-10-15
Completion
2025-04-15
First posted
2025-08-07
Last updated
2025-08-07

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07108933. Inclusion in this directory is not an endorsement.

Scheduled Autologous PRP Guided Injection in the Maxillary Bony Defects (NCT07108933) · Clinical Trials Directory